Colonial Trust
MRNA icon

Colonial Trust’s Moderna MRNA Stock Holding History

Colonial Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$898 Buy
+4
New +$431 ﹤0.01% 1066
2025
Q3 		– Sell
-312
Closed -$8.61K – 1117
2025
Q2 		$8.61K Sell
312
-28
-8% -$737 ﹤0.01% 770
2025
Q1 		$9.6K Buy
340
+25
+8% +$887 ﹤0.01% 756
2024
Q4 		$13.1K Buy
315
+9
+3% +$430 ﹤0.01% 900
2024
Q3 		$20.4K Buy
306
+6
+2% +$551 ﹤0.01% 707
2024
Q2 		$35.6K Hold
300
– – 0.01% 566
2024
Q1 		$32K Sell
300
-2
-0.7% -$202 0.01% 581
2023
Q4 		$30K Sell
302
-33
-10% -$2.78K 0.01% 575
2023
Q3 		$34.6K Buy
335
+35
+12% +$3.9K 0.01% 540
2023
Q2 		$36.4K Hold
300
– – 0.01% 523
2023
Q1 		$46.1K Hold
300
– – 0.01% 474
2022
Q4 		$53.9K Buy
+300
New +$49.1K 0.01% 429

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $2.62B AUM 125.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Colonial Trust's MRNA Position: Q3 2026 in Review

Colonial Trust opened a new position in Moderna (MRNA) in Q3 2026: 4 shares worth $898. The stake represents ﹤0.01% of the portfolio and ranks #1066 among its holdings. This is a return to the name: Colonial Trust previously reported a position in MRNA as recently as Q2 2025.

Colonial Trust first reported a position in MRNA in Q4 2022 and has held it in 12 quarters since. The position peaked at $53.9K in Q4 2022. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Colonial Trust held 4 shares of Moderna worth $898 as of Q3 2026.
  • Moderna was a new Colonial Trust position in Q3 2026.
  • Moderna made up ﹤0.01% of Colonial Trust's portfolio in Q3 2026, its #1066 holding.
  • Colonial Trust first reported a position in Moderna in Q4 2022 and has held it in 12 quarters since.
  • Colonial Trust's Moderna position peaked at $53.9K in Q4 2022.
  • 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Colonial Trust's 13F filing for Q3 2026, filed 10 Nov 2026.